Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (5y) (2020 - 2026)
Powered by 
Analysis
Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.90% |
| Mar 31, 2026 | 23.39% |
| Dec 31, 2025 | 21.58% |
| Sep 30, 2025 | 21.80% |
| Jun 30, 2025 | 30.22% |
| Mar 31, 2025 | 31.67% |
| Dec 31, 2024 | 33.12% |
| Sep 30, 2024 | 32.09% |
| Jun 30, 2024 | 26.33% |
| Mar 31, 2024 | 39.82% |
| Dec 31, 2023 | 28.03% |
| Sep 30, 2023 | 29.59% |
| Jun 30, 2023 | 29.81% |
| Mar 31, 2023 | 38.03% |
| Dec 31, 2022 | 49.54% |
| Sep 30, 2022 | 46.36% |
| Jun 30, 2022 | 38.88% |
| Mar 31, 2022 | 48.65% |
| Dec 31, 2021 | 50.01% |
| Sep 30, 2021 | 57.35% |